- Report
- May 2024
- 192 Pages
Global
From €3241EUR$3,374USD£2,790GBP
€3601EUR$3,749USD£3,100GBP
- Report
- January 2024
- 200 Pages
Global
From €4802EUR$5,000USD£4,134GBP
- Report
- February 2024
- 120 Pages
Global
From €4562EUR$4,750USD£3,928GBP
- Report
- March 2023
- 130 Pages
Global
From €5715EUR$5,950USD£4,920GBP
- Report
- April 2021
- 150 Pages
Asia Pacific
From €2017EUR$2,100USD£1,736GBP
€2881EUR$3,000USD£2,481GBP
- Report
- July 2021
- 111 Pages
Global
From €4562EUR$4,750USD£3,928GBP
- Report
- January 2021
- 143 Pages
Global, China
From €3000EUR$3,346USD£2,673GBP
- Report
- November 2022
- 76 Pages
Global
From €1921EUR$2,000USD£1,654GBP
- Report
- May 2024
- 50 Pages
Global
From €2545EUR$2,650USD£2,191GBP
Famotidine is a medication used to treat gastrointestinal disorders, such as acid reflux and ulcers. It is a histamine-2 receptor antagonist, which works by reducing the amount of acid produced in the stomach. It is available in both prescription and over-the-counter forms. Famotidine is commonly used to treat symptoms of gastroesophageal reflux disease (GERD), peptic ulcers, and other conditions caused by excess stomach acid. It is also used to prevent and treat ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs).
Famotidine is a widely used drug in the gastrointestinal market. It is one of the most commonly prescribed medications for GERD and other acid-related disorders. It is also used to treat and prevent ulcers caused by NSAIDs. Famotidine is generally well-tolerated and has few side effects.
Some companies in the Famotidine market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and Novartis. Show Less Read more
